IDEXX LABORATORIES INC /DE Line of Credit Facility, Maximum Borrowing Capacity
IDEXX LABORATORIES INC /DE (IDXX) had Line of Credit Facility, Maximum Borrowing Capacity of $450.00 million as of 2013-09-30, per its 10-Q filed 2013-10-22.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity · last filed 2013-10-22
- 2013-09-30: Line of Credit Facility, Maximum Borrowing Capacity $450.00M.
- 2013-06-30: Line of Credit Facility, Maximum Borrowing Capacity $450.00M.
- 2013-05-08: Line of Credit Facility, Maximum Borrowing Capacity $300.00M.
| Period end | Line of Credit Facility, Maximum Borrowing Capacity |
|---|---|
| 2013-09-30 | $450.00M 10-Q · filed 2013-10-22 |
| 2013-06-30 | $450.00M 10-Q · filed 2013-07-23 |
| 2013-05-08 | $300.00M 10-Q · filed 2013-10-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |